These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1667007)

  • 1. Relaxometry of paramagnetic liposomes.
    Koenig SH
    Invest Radiol; 1991 Nov; 26 Suppl 1():S260-2; discussion S263-5. PubMed ID: 1667007
    [No Abstract]   [Full Text] [Related]  

  • 2. Entrapment of gadolinium-DTPA in liposomes. Characterization of vesicles by P-31 NMR spectroscopy.
    Devoisselle JM; Vion-Dury J; Galons JP; Confort-Gouny S; Coustaut D; Canioni P; Cozzone PJ
    Invest Radiol; 1988 Oct; 23(10):719-24. PubMed ID: 3192394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theory of paramagnetic contrast agents in liposome systems.
    Barsky D; Pütz B; Schulten K; Magin RL
    Magn Reson Med; 1992 Mar; 24(1):1-13. PubMed ID: 1313522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution and clearance of liposomal gadolinium-DTPA.
    Unger E; Cardenas D; Zerella A; Fajardo LL; Tilcock C
    Invest Radiol; 1990 Jun; 25(6):638-44. PubMed ID: 2354925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
    Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: targeted MRI contrast enhancement agents for the liver.
    Kabalka GW; Davis MA; Moss TH; Buonocore E; Hubner K; Holmberg E; Maruyama K; Huang L
    Magn Reson Med; 1991 Jun; 19(2):406-15. PubMed ID: 1881329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The question of dose for gadolinium chelates in magnetic resonance imaging.
    Runge VM; Kirsch JE; Wells JW; Dunworth JN; Woolfolk CE
    Invest Radiol; 1994 Jun; 29 Suppl 2():S154-6. PubMed ID: 7928215
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 9. MR imaging of pulmonary parenchyma and emboli by paramagnetic and superparamagnetic contrast agents.
    Thakur ML; Vinitski S; Mitchell DG; Consigny PM; Lin S; DeFulvio J; Rifkin M
    Magn Reson Imaging; 1990; 8(5):625-30. PubMed ID: 2082134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA. Results of a randomized, controlled clinical trial.
    Niendorf HP; Haustein J; Louton T; Beck W; Laniado M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S221-3; discussion S232-5. PubMed ID: 1808134
    [No Abstract]   [Full Text] [Related]  

  • 11. [Artificial contrasting during magnetic resonance tomography].
    Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
    Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
    [No Abstract]   [Full Text] [Related]  

  • 12. Pseudolayering of Gd-DTPA in the urinary bladder.
    Elster AD; Sobol WT; Hinson WH
    Radiology; 1990 Feb; 174(2):379-81. PubMed ID: 2296649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total cerebrospinal fluid enhancement following intravenous Gd-DTPA administration in a case of meningiomatosis.
    Berger B; Ortiz O; Gold A; Hilal SK
    AJNR Am J Neuroradiol; 1992; 13(1):15-8. PubMed ID: 1595433
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and medico-legal implications of intra-articular gadolinium use.
    Balkissoon AR
    Semin Ultrasound CT MR; 1997 Aug; 18(4):276-7. PubMed ID: 9285995
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gadolinium-DTPA as an oral contrast medium in magnetic resonance tomography].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Radiol Diagn (Berl); 1989; 30(5):541-8. PubMed ID: 2587719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo target-specific delivery of macromolecular agents with MR-guided focused ultrasound.
    Bednarski MD; Lee JW; Callstrom MR; Li KC
    Radiology; 1997 Jul; 204(1):263-8. PubMed ID: 9205257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for differential enhancement of myocardial ischemia using echoplanar imaging.
    Wendland MF; Saeed M; Higgins CB
    Invest Radiol; 1991 Nov; 26 Suppl 1():S236-8; discussion S245-7. PubMed ID: 1808137
    [No Abstract]   [Full Text] [Related]  

  • 18. Sonographic guidance of needle position for MR arthrography of the shoulder.
    Valls R; Melloni P
    AJR Am J Roentgenol; 1997 Sep; 169(3):845-7. PubMed ID: 9275909
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gadolinium-DTPA as an oral contrast medium for magnetic resonance tomography of the pancreas].
    Neumann K; Kaminsky S; Gogoll M; Clauss W; Langer M; Felix R
    Rofo; 1991 Mar; 154(3):262-8. PubMed ID: 1849293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gd-DTPA: an i.v. contrast agent for clinical MRI.
    Runge VM
    Int J Rad Appl Instrum B; 1988; 15(1):37-44. PubMed ID: 3280522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.